Company CVAbout Shilpa Medicare Ltd 
Shilpa Medicare Ltd
Mid Cap
Pharmaceuticals & Drugs
Shilpa Medicare Limited (Formerly known as Shilpa Antibiotics Private Limited) was incorporated as a Private Limited Company on November 20, 1987. The Company changed the status to Public Limited and the name of the Company was changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C.
Company Coordinates
Company Details
#12-6-214/A1, Hyderabad Road Raichur Karnataka : 584135
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 9.78 Cr
Number of Shares
9.78 Cr
Face Value
INR 1.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
13-Apr-2024
9.78
9.78
10989010
1
Qualified Institutional Placement
12-Nov-2021
8.68
8.68
5275000
1
Preferential basis
16-Dec-2017
8.15
8.15
1399994
1
Amalgamation
26-Dec-2016
8.01
8.01
3025000
1
Allotment of Equity To Others
26-Dec-2016
8.01
8.01
3025000
1
Allotment of Equity To Others
06-Nov-2015
7.71
7.71
38550952
1
Stock Split
06-Nov-2015
7.71
7.71
38550952
1
Stock Split
15-May-2014
3.86
7.71
1764705
2
Allotment of Equity Shares To Promoter & Others
15-May-2014
3.86
7.71
1764705
2
Allotment of Equity Shares To Promoter & Others
16-Jul-2013
3.68
7.36
12262082
2
Bonus
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
7.9191
Mutual Funds
Held by 8 Schemes (4.89%)
FIIs
Held by 92 FIIs (9.9%)
Promoter with highest holding
Vishnukant Chaturbhuj Bhutada (6.51%)
Highest Public shareholder
Icici Prudential Elss Tax Saver Fund (2.4%)
Individual Investors Holdings
24.4%
Board of Directors
Management
Designation
Remuneration
Omprakash Inani
Chairman (Non-Executive)
2.5 lacs
Vishnukant Bhutada
Managing Director
3.5 cr
Sharath Reddy Kalakota
Whole-time Director
1.45 cr
Arvind Vasudeva
Independent Director
30.0 lacs
Hetal Gandhi
Independent Director
40.0 lacs
Ritu Tiwary
Company Sec. & Compli. Officer
0
Kamal K Sharma
Independent Director
22.5 lacs
Anita Bandyopadhyay
Independent Director
12.0 lacs
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Income - Product Development
30.27
4.56%
Other Operating Income - Product Development
Other Operating Income - Product Development
Stock DNARevenue and Profits:
Net Sales:
319 Cr
(Quarterly Results - Dec 2024)
Net Profit:
32 Cr
Pharmaceuticals & Drugs
INR 6,083 Cr (Mid Cap)
72.00
33
0.00%
0.20
2.39%
2.57
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
